Cambridge Healthtech Institute’s 3rd Annual

Bispecific Antibodies for Cancer Immunotherapy

Engineering Next-Generation Biotherapeutics in Immuno-Oncology

August 10-11, 2020



Engaging multiple receptors with bispecific biologics offers the potential to improve upon single-agent checkpoint blockade and promises to be the next generation of immunotherapy. Cambridge Healthtech Institute’s Third Annual Bispecific Antibodies for Cancer Immunotherapy meeting will showcase preclinical, translational, and clinical studies on using bispecific antibodies for dual blockade of checkpoint targets, T cell-redirecting bispecific biologics, and overcoming T cell exhaustion, as well as strategies to improve efficacy and reduce toxicity, and to engineer the next generation of bi- and multi-specific biologics.

Coverage will include, but is not limited to:

  • Reviving exhausted T cells with dual costimulation
  • Engaging inhibitory and agonist receptors with bispecific biologics
  • Improving on-target efficacy and limiting off-target immunotoxicity
  • Preclinical and translational research for bispecific antibodies
  • T cell-redirecting bispecific antibodies
  • Engineering bispecific and multi-specific platforms and constructs

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is January 31, 2020.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:

Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute
Email: juliab@healthtech.com

For partnering and sponsorship information, please contact:

Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-247-6286
Email: reymael@healthtech.com


Connect With Us

MEETING SUGGESTIONS

For meeting questions or suggestions, please contact:

Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute
juliab@healthtech.com

PARTNERING & SPONSORSHIP

For partnering and sponsorship info, please contact:

Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
+1 781.247.6286
reymael@healthtech.com

MEDIA & ASSOCIATION

For media and association partnerships, please contact:

Pete DeOlympio
Sr. Marketing Manager
Cambridge Healthtech Institute
+1 781.972.5415
peted@healthtech.com